<DOC>
	<DOCNO>NCT00971945</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy continue administration paclitaxel give weekly subject consider need continue treatment completion precede `` Phase II Clinical Study Weekly Paclitaxel ( BMS-181339 ) Advanced Breast Cancer ( Protocol No . CA139-371 ) ''</brief_summary>
	<brief_title>Rollover Study Weekly Paclitaxel ( BMS-181339 ) Patients With Advanced Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Subjects confirm response receive least two course weekly paclitaxel therapy consider need continue therapy investigator/subinvestigator among patient advanced recurrent breast cancer meet selection criterion participate precede phase II clinical study</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>